Margue C - Search Results

1

Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug response.

Randic T, Magni S, Philippidou D, Margue C, Grzyb K, Preis JR, Wroblewska JP, Nazarov PV, Mittelbronn M, Frauenknecht KBM, Skupin A, Kreis S. Randic T, et al. Among authors: margue c. Cell Rep. 2023 Jul 25;42(7):112696. doi: 10.1016/j.celrep.2023.112696. Epub 2023 Jun 29. Cell Rep. 2023. PMID: 37379213 Free article.

2

Jaks and cytokine receptors--an intimate relationship.

Haan C, Kreis S, Margue C, Behrmann I. Haan C, et al. Among authors: margue c. Biochem Pharmacol. 2006 Nov 30;72(11):1538-46. doi: 10.1016/j.bcp.2006.04.013. Epub 2006 Apr 27. Biochem Pharmacol. 2006. PMID: 16750817 Review.

3

Recombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells.

Kreis S, Philippidou D, Margue C, Rolvering C, Haan C, Dumoutier L, Renauld JC, Behrmann I. Kreis S, et al. Among authors: margue c. PLoS One. 2007 Dec 12;2(12):e1300. doi: 10.1371/journal.pone.0001300. PLoS One. 2007. PMID: 18074024 Free PMC article.

4

IL-24: a classic cytokine and/or a potential cure for cancer?

Kreis S, Philippidou D, Margue C, Behrmann I. Kreis S, et al. Among authors: margue c. J Cell Mol Med. 2008 Dec;12(6A):2505-10. doi: 10.1111/j.1582-4934.2008.00372.x. J Cell Mol Med. 2008. PMID: 18505472 Free PMC article. Review.

5

Signatures of microRNAs and selected microRNA target genes in human melanoma.

Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A, Vallar L, Nashan D, Behrmann I, Kreis S. Philippidou D, et al. Among authors: margue c. Cancer Res. 2010 May 15;70(10):4163-73. doi: 10.1158/0008-5472.CAN-09-4512. Epub 2010 May 4. Cancer Res. 2010. PMID: 20442294

6

IL-24: physiological and supraphysiological effects on normal and malignant cells.

Margue C, Kreis S. Margue C, et al. Curr Med Chem. 2010;17(29):3318-26. doi: 10.2174/092986710793176311. Curr Med Chem. 2010. PMID: 20712572 Review.

7

MiRNA-29: a microRNA family with tumor-suppressing and immune-modulating properties.

Schmitt MJ, Margue C, Behrmann I, Kreis S. Schmitt MJ, et al. Among authors: margue c. Curr Mol Med. 2013 May;13(4):572-85. doi: 10.2174/1566524011313040009. Curr Mol Med. 2013. PMID: 22934851 Review.

8

Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells.

Schmitt MJ, Philippidou D, Reinsbach SE, Margue C, Wienecke-Baldacchino A, Nashan D, Behrmann I, Kreis S. Schmitt MJ, et al. Among authors: margue c. Cell Commun Signal. 2012 Dec 17;10(1):41. doi: 10.1186/1478-811X-10-41. Cell Commun Signal. 2012. PMID: 23245396 Free PMC article.

9

New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion.

Margue C, Philippidou D, Reinsbach SE, Schmitt M, Behrmann I, Kreis S. Margue C, et al. PLoS One. 2013 Sep 5;8(9):e73473. doi: 10.1371/journal.pone.0073473. eCollection 2013. PLoS One. 2013. PMID: 24039954 Free PMC article.

10

Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?

Margue C, Reinsbach S, Philippidou D, Beaume N, Walters C, Schneider JG, Nashan D, Behrmann I, Kreis S. Margue C, et al. Oncotarget. 2015 May 20;6(14):12110-27. doi: 10.18632/oncotarget.3661. Oncotarget. 2015. PMID: 25883223 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page